arBtrage CAPITALIZING MARKETS checking… Sign in Sign up

Ocular Therapeutix, Inc.

OCUL Health Care Biotechnology: Pharmaceutical Preparations
$8.25
▼ -6.2% Today
as of Jun 7, 07:23 ET
Last 30 days -11.48% Apr 28 → Jun 05
$7.85 $8.36 $8.88 $9.40 $9.91 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$8.82
High
$8.88
Low
$8.16
Volume
$1M
Avg Vol
$4M
Mkt Cap
$2.0B
P/E (TTM)
Beta
52w High
$16.44
52w Low
$6.23
Div Yield
Shares Out
$219M

Overview

52-week range
$6.23
$16
20% of range
Avg surprise (last 2)
-27.9%
Avg reaction (last 2)
-6.4%
0% positive
Latest IV / EM
94%
EM ±8.8% · $8 · Jun 12

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.49$-0.42$-0.35$-0.29$-0.22 Actual $-0.26Actual $-0.25Actual $-0.49Actual $-0.26Actual $-0.22Actual $-0.37Est $-0.29Actual $-0.39Actual $-0.38Actual $-0.41Est $-0.32 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-89M$-76M$-63M$-51M$-38M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue May 5, 2026Mar/2026 $-0.41 $-0.32 -28.1% -10.8% -0.6% earnings
Tue Sep 30, 2025Sep 2025 $-0.38 financials
Mon Jun 30, 2025Jun 2025 $-0.39 financials
Mon May 5, 2025Mar/2025 $-0.37 $-0.29 -27.6% -12.2% earnings
Mon Sep 30, 2024Sep 2024 $-0.22 financials
Sun Jun 30, 2024Jun 2024 $-0.26 financials
Sun Mar 31, 2024Mar 2024 $-0.49 financials
Sat Sep 30, 2023Sep 2023 $-0.25 financials
Fri Jun 30, 2023Jun 2023 $-0.26 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue
Cost of revenue$1M$2M$2M$1M$2M$2M
Gross profit
Operating income$-93M$-69M$-68M$-64M$-46M$-44M
Net income$-89M$-69M$-68M$-64M$-36M$-44M
EPS (diluted)$-0.40$-0.38$-0.39$-0.38$-0.22$-0.26

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$667M$737M$345M$391M$350M$392M$427M$460M
Inventory$4M$4M$3M$3M$3M$3M$2M$3M
Total current assets$706M$782M$387M$433M$388M$441M$473M$499M
Total assets$733M$808M$411M$451M$406M$458M$490M$517M
Long-term debt
Total liabilities$151M$154M$153M$145M$140M$143M$138M$139M
Total equity$582M$654M$258M$306M$266M$315M$352M$378M

Implied volatility — last 90 days

89%91%94%96%99% Jun 07 — IV 94% · EM ±8.8%

Sector peers

🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.